Orgenesis (STU:45O0) E10: €0.00 (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:45O0 Orgenesis Inc STU:45O0
12 GF Score
Price €3.40
View Full Analysis

What is Orgenesis E10?

Orgenesis STU:45O0 12 E10 is €0.00 as of Dec. 2024. GuruFocus rates STU:45O0 with a GF Score™ of 12/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Orgenesis's adjusted earnings per share data for the three months ended in Dec. 2024 was €-4.183. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.00 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-24), Orgenesis's current stock price is €3.40. Orgenesis's E10 for the quarter that ended in Dec. 2024 was €0.00. Orgenesis's Shiller PE Ratio of today is .


Orgenesis  (STU:45O0) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Orgenesis E10 Related Terms


Orgenesis E10 Historical Data

* Premium members only.

The historical data trend for Orgenesis's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orgenesis E10 Chart

Orgenesis Annual Data
Trend Nov15 Nov16 Nov17 Nov18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.32 -9.78 -11.01 -12.71 0.00

Orgenesis Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.71 -13.71 -13.66 -10.70 0.00

STU:45O0 vs ENDV, GBLX, OMGAQ: E10 Comparison

For the Biotechnology subindustry, Orgenesis's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orgenesis Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Orgenesis's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Orgenesis's Shiller PE Ratio falls into.


STU:45O0
12GF Score
Orgenesis Inc STU:45O0
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orgenesis E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Orgenesis's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-4.183/315.6050*315.6050
=-4.183

Current CPI (Dec. 2024) = 315.6050.

Orgenesis Quarterly Data

per share eps CPI Adj_EPS
201502 -2.114 234.722 -2.842
201505 -3.222 237.805 -4.276
201508 -4.310 238.316 -5.708
201511 -2.237 237.336 -2.975
201602 0.108 237.111 0.144
201605 -4.243 240.229 -5.574
201608 -2.141 240.849 -2.806
201611 -5.377 241.353 -7.031
201702 -6.197 243.603 -8.029
201705 -2.353 244.733 -3.034
201708 -3.388 245.519 -4.355
201711 0.256 246.669 0.328
201802 -4.212 248.991 -5.339
201805 -1.692 251.588 -2.123
201808 -3.031 252.146 -3.794
201811 -3.432 252.038 -4.298
201903 -4.868 254.202 -6.044
201906 -3.186 256.143 -3.926
201909 -3.995 256.759 -4.911
201912 -3.780 256.974 -4.642
202003 38.281 258.115 46.807
202006 -8.436 257.797 -10.328
202009 -0.934 260.280 -1.133
202012 -18.659 260.474 -22.608
202103 -0.084 264.877 -0.100
202106 -0.913 271.696 -1.061
202109 -3.570 274.310 -4.107
202112 -1.770 278.802 -2.004
202203 -1.453 287.504 -1.595
202206 -2.081 296.311 -2.217
202209 -0.505 296.808 -0.537
202212 -1.510 296.797 -1.606
202303 -8.126 301.836 -8.497
202306 -7.015 305.109 -7.256
202309 -0.112 307.789 -0.115
202312 -15.937 306.746 -16.397
202403 -2.668 312.332 -2.696
202406 -2.137 314.175 -2.147
202409 -1.739 315.301 -1.741
202412 -4.183 315.605 -4.183

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.00 mean?
Orgenesis (STU:45O0) has a E10 of €0.00 as of Dec. 2024. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Orgenesis and its competitors.
Is Orgenesis' E10 too high?
Orgenesis' current E10 is €0.00. Overall, Orgenesis has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Orgenesis' E10 compare to ENDV and GBLX?
Orgenesis' E10 of €0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Orgenesis and its competitors. Orgenesis's current E10 is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orgenesis stock overvalued right now?
Orgenesis (STU:45O0) has a current E10 of €0.00. The current E10 is €0.00. Orgenesis' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Orgenesis (STU:45O0), the current E10 is €0.00 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Orgenesis Business Description

Address 20271 Goldenrod Lane, Germantown, MD, USA, 20876
Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Octomera and Therapies. The company's therapies pipeline includes Immuno-Oncology, Viral Diseases, Metabolic & Autoimmune Diseases, Vascular & Musculoskeletal Diseases, and Kidney Disease.
12GF Score

Get the complete analysis for STU:45O0

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.40
Price